WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 6'5301 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 15'5791 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 9'405  9'450  9'491  9'526  9'556  9'981  10'260  9'659 
Births 103  104  104  103  102  88  143  157 
Surviving infants 103  103  103  102  101  87  141  154 
Pop. less than 5 years 526  523  509  500  486  461  807  745 
Pop. less than 15 years 1'423  1'416  1'409  1'415  1'423  1'861  2'367  2'210 
Female 15-49 years 2'382  2'421  2'459  2'496  2'531  2'637  2'482  2'502 

Number of reported case

(Click for retrospective incidence data for Belarus)
Diphtheria 52  22 
Japanese encephalitis
Measles 10  50  21  224 
Mumps 61  48  88  172  245  19'069 
Pertussis 576  151  112  93  125  169  462 
Polio*
Rubella 10  20  16'034 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Belarus)
Vaccine year result method % card seen                                                
BCG          98  99  99  98  98  99 
DTP1          99  99  97  98  98 
DTP3          98  99  98  97  97  99 
HepB_BD          98  98  98  98  98 
HepB3          97  98  96  98  98  70 
Hib3          99  100  93  96 
JapEnc         
MCV          98  99  99  99  99  98 
MCV2          97  99  99  99  99  92 
PCV1         
PCV3         
Pol3          98  99  99  99  98  99 
Rota1         
Rota_last         
Rubella1          98  99  99  99  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Belarus)
BCG 98  99  99  98  98  99 
DTP1 98  99  99  98  98  99 
DTP3 98  98  98  96  97  99 
HepB3 97  98  96  98  98  70 
Hib3 22  21  19 
MCV 98  99  99  99  99  98 
PCV3
Pol3 98  98  99  98  98  99 
Rota_last

Number of districts in the country 121  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; 7, 14 years; Yes
DT 6 years; Yes
DTaPHibIPV 3, 4, 5 months; No
DTaPIPV 3, 4, 5 months; No
DTwP 3, 4, 5, 18 months; Yes
HepB 1 day; 1, 5 months; Yes and HCW
IPV 3, 4, 5 months; Yes
Influenza Yes high risk groups
MMR 12 months; 6 years; Yes
OPV 18, 24 months; Yes
TT Yes emergencies
Td 16 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 
What years does the MYP cover? number 2007-2012  2007-2012  2007-2012  2007-2012  2007-2012    2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 121          119   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 121  130  130  119  119  119  138 
Nº districts with DTP3 coverage >=80% number 121  130  130  119  119  119  138 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 121  130  130  119  119     
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  No           

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 47  NA  NA  75  75  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.